Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.

Consultant in endocrinology and diabetes Professor Vinod Patel discusses current recommended pharmacological treatment ...

Hyderabad: The 84th All India Industrial Exhibition, which is also called Numaish, concluded on Monday. By Sunday, 19.72 lakh ...

Nectar Life Care launches affordable anti-diabetic range to improve accessibility: Our Bureau, Mumbai Tuesday, February 18, 2025, 12:15 Hrs [IST] Nectar Life Care has announced th ...

The Indian phenotype of T2DM patients is associated with clustering of cardiovascular risk factors, increased insulin ...

Kolkata: Prices of 42 medicines, including those used for day-to-day consumption, are likely to change following an order by ...

Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...

Metformin, a widely used medication for type 2 diabetes, may also help slow cognitive decline and reduce the risk of dementia, according to a study from UNSW Sydney. The research suggests that ...

Since diabetic patients commonly use metformin and are also at higher risk of renal dysfunction, this case highlights the vulnerability of this group of patients and the need for increased knowledge ...

With its recent data drop for an oligonucleotide candidate, Dyne Therapeutics signals it may become a frontrunner in this ...

A recent study has found that a class of diabetes drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors may increase ...

Jaipur: The Union Ayush Ministry has directed authorities in West Bengal to investigate reports of adulteration in an ...